by MASA | Aug 8, 2024 | Celiac Disease
In this 2-minute radio interview, Dr. Siri explains the difference between Celiac Disease and Gluten intolerance and announces the clinical study for a celiac new treatment in the SWIA research center in Normal, IL. Have a listen and share! Text transcription:...
by MASA | Jul 31, 2024 | Drug Updates
The FDA approved Zoryve cream (0.15%) for mild to moderate atopic dermatitis this year for adults and children aged above 6 years old. Roflumilast cream (marketed under the name Zoryve) is a non-steroidal topical cream that is applied once daily to affected areas of...
by MASA | May 13, 2024 | Immunodeficiency Hypogammaglobulinemia, Uncategorized
As allergists, your providers not only deal with over-reactions of your immune system but also immunodeficiency. Listen to the 3-minute clip to learn the brief introduction to immunodeficiency by Dr. Dareen Siri to understand if you or your loved ones may have...
by MASA | Apr 23, 2024 | Drug Updates, News
The U.S. Food and Drug Administration (FDA) has provided an emergency use authorization (EUA) for a new medicine called Pemgarda™ (pemivibart), aimed at preventing COVID-19 in certain high-risk individuals. This medication is specifically designed for those who are...
by MASA | Mar 31, 2024 | Drug Updates
US FDA approved of XHANCE as the first and only medication for adults with chronic rhinosinusitis without nasal polyps. It is a fluticasone propionate nasal spray which uses the Exhalation Delivery System to enable topical steroid to the inflamed areas and is proven...
